Skip to main content
SupplementScience

Pine Bark Extract (Pycnogenol) Research & Evidence

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence Level

Strong

Pycnogenol has one of the strongest evidence bases in the supplement industry, with over 160 published clinical studies. For men's health, the landmark study by Stanislavov & Nikolova (2003) showed that the combination of Pycnogenol 120mg + L-arginine 3g daily (marketed as Prelox) restored normal erectile function in 92.5% of men with organic erectile dysfunction after 3 months. The mechanism involves Pycnogenol's ability to stimulate eNOS and increase nitric oxide production, which is synergistically enhanced by L-arginine (the substrate for NO synthesis). Subsequent studies by Stanislavov et al. (2008, 2014) confirmed these findings in larger populations. Beyond sexual health, Pycnogenol has strong evidence for cardiovascular protection, with Enseleit et al. (2012) publishing a double-blind RCT showing improved endothelial function in coronary artery disease patients. Liu et al. (2004) demonstrated glycemic benefits as an adjunct to diabetes medication.

Evidence by Condition

ConditionStudied DoseEvidence
Erectile function (Prelox)120mg Pycnogenol + 3g L-arginine aspartate dailyStrong
Cardiovascular health100-150mg dailyStrong
Blood sugar management100-200mg daily as adjunct therapyModerate
General antioxidant support50-100mg dailyModerate

References

  1. (). Treatment of erectile dysfunction with pycnogenol and L-arginine. Journal of Sex and Marital Therapy. DOI
  2. (). Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. European Heart Journal. DOI
  3. (). Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sciences. DOI